Status:
COMPLETED
Influence of Percutaneous Electrolysis on Endogenous Pain Modulation
Lead Sponsor:
University of Salamanca
Conditions:
Pain
Eligibility:
All Genders
18-40 years
Phase:
NA
Brief Summary
Percutaneous electrolysis is a minimally invasive approach that consists in the application of a galvanic current through an acupuncture needle. Although several mechanisms and effects are attributed ...
Eligibility Criteria
Inclusion
- Healthy asymptomatic subjects
- Aged 18 to 40 years
- Both genders
Exclusion
- Belonephobia or fear of needles
- Neurological, cardiovascular or metabolic diseases
- Any pathology or process that causes pain
- Cutaneous alterations
- Pregnancy
- Cognitive and sensitivity disorders
- Fibromyalgia
- Frequent or recent (24 hours before) intake of alcohol and other drugs
- Have received pharmacological, physiotherapeutic or other treatment in the last week
- Intake of caffeine in the two hours prior to measurement
- Vigorous physical activity on the day of testing
Key Trial Info
Start Date :
October 3 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 23 2022
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT04710992
Start Date
October 3 2022
End Date
December 23 2022
Last Update
January 26 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Facultad de Enfermería y Fisioterapia de la Universidad de Salamanca
Salamanca, Spain, 37007